Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Fusion Success Between NanoBone Synthetic Bone Graft and Local Autogenous Bone Graft in Posterolateral Spinal Fusion

NCT04615260 is registered in ClinicalTrials.gov with Artoss Inc. as lead sponsor.

NCT NCT04615260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04615260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Fusion Success Between NanoBone Synthetic Bone Graft and Local Autogenous Bone Graft in Posterolateral Spinal Fusion
Lead sponsor
Artoss Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 19, 2021
Completion date
April 30, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, spondylolisthesis